Xingxing Yuan (Yuan Xingxing)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Oxidative Stress

Natural Killer Cells

Top Venues

Cell biochemistry and function

Experimental biology and medicine (Maywood, N.J.)

Mediators of inflammation

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Xingxing Yuan, Yurong Tan, Ousman Bajinka, Modou L Jammeh, Abubakarr Dukureh, Chidera N Obiegbusi, Khalid A Abdelhalim, Mahmoud Mohanad
The connection between epigenetics and gut microbiota-current perspective. Cell biochemistry and function 42 (2) (2024)
Xingxing Yuan, Yurong Tan, Ousman Bajinka, Modou L Jammeh, Abubakarr Dukureh, Chidera N Obiegbusi, Khalid A Abdelhalim, Mahmoud Mohanad
The connection between epigenetics and gut microbiota-current perspective. Cell biochemistry and function 42 (2) (2024)
Xingxing Yuan, Yurong Tan, Ousman Bajinka, Modou L Jammeh, Abubakarr Dukureh, Chidera N Obiegbusi, Khalid A Abdelhalim, Mahmoud Mohanad
The connection between epigenetics and gut microbiota-current perspective. Cell biochemistry and function 42 (2) (2024)
Lijie Wang, Xingxing Yuan, Zhuying Li, Fumin Zhi
The Role of Macrophage Autophagy in Asthma: A Novel Therapeutic Strategy. Mediators of inflammation 2023 (2023)
Cong Feng, Xingxing Yuan
Role of autophagy and its regulation by noncoding RNAs in ovarian cancer. Experimental biology and medicine (Maywood, N.J.) (2023)
Lijie Wang, Xingxing Yuan, Zhuying Li, Fumin Zhi
The Role of Macrophage Autophagy in Asthma: A Novel Therapeutic Strategy. Mediators of inflammation 2023 (2023)
Hailong Zhang, Gang Liu, Xu Mao, Lei Yang, Bingyu Wang, Xingxing Yuan
LncRNA MEG3 induces endothelial differentiation of mouse derived adipose-derived stem cells by targeting MiR-145-5p/KLF4. Molecular biology reports 49 (9) (2022)
Yuan Wei, Wang Bingyu, Yang Lei, Xingxing Yuan
The antifibrotic role of natural killer cells in liver fibrosis. Experimental biology and medicine (Maywood, N.J.) 247 (14) (2022)